Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Nuvo Research Inc T.NRI

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  NRIFF | NRIFD

Nuvo Research, Inc. is a Canadian specialty pharmaceutical company with manufacturing operations. The Company operates two distinct business units: the Topical Products and Technology (TPT) Group (formerly the Pain Group) and the Immunology Group.
Price: $8.07 | Change: +$0.24 | %Change: +3.07%
Volume: 57,638 | Day High/Low: 8.15/7.87 | 52 Week High/Low: 8.33/2.40
View modes: 
4 stars

RE:Extrapolation of initial trial results to P2

For those who are statistically minded, see slide 8 of the corporate presentation. You will note the temporal divergence in the TNSS index between the placebo and those given WF10. After 12 weeks the...read more
5 stars

Inferred valuation of WF10

Let's look at a very good proxy....,Circasia's 4 Spires of which the cat is in P111 and the other three are in various stages of P2. WF10 will do the same job for all 4 allergies ( cat , grass...read more
4.5 stars

Extrapolation of initial trial results to P2

Lets lets look at the reliability of the statistical projections of the initial trial to Phase 2 results . First, unlike most P 2 trials, this one for WF10 is not about safety. WF10 has several...read more
5 stars

Let us hope that today's run continues

tomorrow,  rate and reply
3 stars

Globe and Mail article - Normally, I steer clear of biotech

I went back through historical posts and I don't think this article ever made it to the bullboard. It is worth the read. http://www.theglobeandmail.com/globe-investor/investment-ideas/nuvo-research...read more
0 stars

RE:question for those familiar with scientific trial protocol

Both your first and second paragraphs are true. In this case, they have announced everyone has finished the trial. Now they have to analyze the results. The company may have some inferences from the...read more
1 star

question for those familiar with scientific trial protocol

at thsi stage is there an chance the researchers/clinicians involved in the trial may have an inclination of the results of the PII study based on any factors?  my layman's understanding is that until...read more
5 stars

RE:RE:RE:RE:News!!

In the July 30th Q2 results management advised WF10 results to be released in Q1 2015, no mention ever of January. "The Company expects the study to be completed in late 2014 with top-line results...read more
2 stars

RE:RE:RE:News!!

The June 2014 Investor Presentation shows WF10 Phase 2 study results in Q4 2014. Where specifically they changed the date to January I am less sure and if it is important I'll do some digging later...read more
0 stars

RE:RE:News!!

The extra time is to ensure that all results are ultimately linked to what FDA might require for Phase 111. In the longer haul, saving time.  rate and reply
4 stars

RE:RE:News!!

C99- After the initial "slippage", where were they saying January? All I remember is 1st quarter. Just curious... I'm sure I missed it somewhere.  rate and reply
0 stars

RE:RE:What happened re the knee capping

Thanks - certainly good to see the resumption of the uptrend.  Perversely I was seeing the capping as possibly positive as someone doing sometjing relaated to a NASDAQ listing - which would actually...read more
1 star

RE:What happened re the knee capping

The "capping" was only a conspiracy theory with no verifiable evidence of any intentions.  The stock didn't have a reason to go higher. Now there is some news that is being taken as positive.  rate and reply
5 stars

What happened re the knee capping

I am mystified re what going on.  Have seen the capping of the price for last few weeks.  Not clear what the purpose was.  However news today and the SP rising and the limiting sales don't seem to be...read more
1 star

RE:News!!

The timing for the results slipped again - from Q4 2014 to January and now to mid-February. That said, I am pleased that management revised the timeline and advised shareholders/investors accordingly...read more
0 stars

Nuvo Research® reports that all patients have completed Phas

Nuvo Research® reports that all patients have completed Phase 2 study of WF10™ for the treatment of allergic rhinitis http://www.newswire.ca/en/story/1465473/nuvo-research-reports-that-all-patients...read more
5 stars

RE:News!!

According to Cannacords valuation model for Circassia's Spire allergic drugs, a successful Phase 11 trial has a substantial impact on drug valuation. Discounted NPV rises by about 2.5 times to about...read more
5 stars

RE:News!!

Its looking very good too, as the veneer on the quotes indicates... ...."These unique attributes //////make ///////// WF10 a revolutionary product candidate for patients who don't obtain adequate...read more
5 stars

News!!

Nuvo Reports that all patients have completed the Phase 2 study, and results will be released Mid-February 2015 !!  rate and reply
5 stars

RE:New Technical Signal

Thank you. That is very encouraging. The Santa Claus Rally has begun and with greater clarity by the Fed yesterday about increased flexibility to defer rate increases, we should see a very strong end...read more